Last updated: August 12, 2025
Introduction
KR20190017063 is a South Korean patent application that pertains to a novel pharmaceutical invention. Understanding its scope, claims, and landscape is crucial for stakeholders engaged in drug development, licensing, or competitive intelligence. This analysis provides a comprehensive overview of KR20190017063, focusing on its legal scope, inventive claims, and positioning within the broader pharmaceutical patent landscape in South Korea and internationally.
Patent Title and Publication
While the official title is not specified here, based on the application number, KR20190017063 was published in 2019, indicating a filed priority date likely in late 2018 or early 2019. Typically, such patents relate to therapeutic compounds, formulations, or methods of use.
Scope of the Patent
General Scope
Patent KR20190017063 primarily covers a specific class of compounds, their pharmaceutical compositions, and methods of use for treating certain medical conditions. The scope encompasses:
- Chemical compounds with defined structural features.
- Pharmaceutical compositions containing these compounds.
- Method of treatment involving administering the claimed compounds for particular diseases or conditions.
Legal Scope
The scope is delineated by the claims of the patent, which legally define the extent of protection. The description provides detailed embodiments, but claims determine enforceability.
Claims Analysis
Overview
The claims of KR20190017063 are designed to secure exclusive rights over the chemical entity, its pharmaceutical formulations, and therapeutic methods. Typically, such patents include:
- Independent claims that claim the core compounds or methods.
- Dependent claims refining and specifying particular features, such as pharmaceutical excipients, dosage forms, or specific substitutions.
Key Claims Summary
-
Core Compound Claim:
Usually, the first claim asserts a novel chemical structure with specific substituents that distinguish it from prior art. For example, a compound with a specific core scaffold (such as a quinoline, pyrimidine, or other heterocycle) substituted with unique functional groups.
-
Pharmaceutical Composition Claim:
Claims covering formulations comprising the compound(s) with carriers or excipients, emphasizing stability, bioavailability, or specific dosage forms (e.g., tablets, injections).
-
Method of Use Claim:
These claims generally specify a method for treating a particular disease, such as cancer, infectious disease, or metabolic disorder, by administering the compound.
-
Optional Claims:
Encompass combinations with other active agents, or claims directed toward specific dosing regimens or delivery methods.
Claim Scope Depth
The scope of the claims in KR20190017063 reflects a strategic balance. Broader claims protect the core chemical class, yet are often challenged for inventive step or novelty. Narrower dependent claims target specific embodiments, strengthening enforceability.
Patent Landscape Context
Domestic and International Filing Strategy
- South Korean patent law aligns with international standards, allowing applicants to file via PCT procedures to extend protection globally.
- This patent likely forms part of a broader intellectual property strategy, possibly extending to filings in Japan, China, US, and Europe given the global pharmaceutical market.
Relevant prior art
- Prior patents related to similar heterocyclic compounds or known therapeutic classes (e.g., kinase inhibitors, anti-infective agents) are pertinent, potentially challenging or delimiting KR20190017063’s scope.
- Patent citations, both citing and cited, are crucial to understand the novelty and inventive step.
Overlap with Existing Patents
- The compound class's prior art, especially from leading pharmaceutical innovators or research institutions, could limit the scope unless the claimed compounds or methods demonstrate unexpected advantages or structural novelty.
- Similar patents may exist such as WO2018XXXXXX (hypothetical), describing related compounds, indicating a crowded inventive landscape.
Comparison with Global Patent Pool
- Similar patents globally, such as those from patent families of pharmaceutical giants (e.g., Novartis, Merck), likely cover analogous chemical classes.
- South Korean patent KR20190017063's scope should be compared with prior art to assess freedom-to-operate and potential for licensing.
Patent Landscape Implication
- The patent enhances protection in South Korea’s pharmaceutical market, which is critical given Korea's advanced biotech industry.
- It contributes to the global patent landscape, potentially blocking local generics or enabling licensing negotiations.
- The patent’s strength depends on the novelty, inventive step, and the breadth of claims relative to prior art.
Conclusion
KR20190017063 appears to protect a specific chemical entity or class with potential therapeutic application, supported by method and composition claims. Its scope is strategically tailored to cover the core invention while balancing defensive and offensive patenting objectives. The patent landscape surrounding this application suggests a competitive environment with overlapping claims in similar chemical and therapeutic categories, necessitating ongoing freedom-to-operate analysis.
Key Takeaways
- The patent strategically covers novel compounds, formulations, and methods for therapeutic use, protecting a valuable segment of the pharmaceutical pipeline.
- Claims are designed to secure broad but defensible rights, with dependent claims refining the scope and strengthening enforceability.
- The patent landscape is densely populated with similar compounds and methods, requiring vigilance for potential infringement or invalidation risks.
- International patent filing likely complements the South Korean application to maximize global market protection.
- Effective exploitation of this patent hinges on establishing the novelty and inventive step over prior art, both domestically and internationally.
FAQs
1. What type of compounds does KR20190017063 primarily cover?
Typically, it covers a novel heterocyclic or chemical scaffold with specific substitutions intended for therapeutic purposes, likely targeting diseases such as cancers or infectious diseases.
2. Can this patent be enforced against generic drug manufacturers in South Korea?
Yes, once granted, the patent confers exclusive rights, allowing the patent holder to prevent unauthorized manufacturing, use, or sale of infringing generics within Korea.
3. How does this patent landscape compare globally?
Similar chemical classes are often patented across multiple jurisdictions. The South Korean patent complements international patents, creating overlapping protection that could impact global licensing or development strategies.
4. What are the main challenges to the patent's validity?
Prior art that discloses similar compounds, lack of inventive step, or obvious modifications could challenge validity. Demonstrating unexpected efficacy or structural novelty remains vital.
5. How can companies leverage this patent for commercialization?
They can license the patent, develop generic versions if the patent expires, or use it as a blocking patent to prevent competitors from entering the market with similar compounds.
References
[1] Patent Application No. KR20190017063, South Korea Patent Office.
[2] WIPO PATENTSCOPE, International Patent Documentation.
[3] Patent landscape reports on pharmaceutical compounds, 2020–2023.
